[go: up one dir, main page]

FI870457L - Farmaceutiska preparatformer foer stabilisering av interferon. - Google Patents

Farmaceutiska preparatformer foer stabilisering av interferon. Download PDF

Info

Publication number
FI870457L
FI870457L FI870457A FI870457A FI870457L FI 870457 L FI870457 L FI 870457L FI 870457 A FI870457 A FI 870457A FI 870457 A FI870457 A FI 870457A FI 870457 L FI870457 L FI 870457L
Authority
FI
Finland
Prior art keywords
stabilisering
preparatformer
foer
interferon
pharmaceutical
Prior art date
Application number
FI870457A
Other languages
English (en)
Other versions
FI86144B (fi
FI870457A0 (fi
FI86144C (fi
Inventor
Helmut Franz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI870457A0 publication Critical patent/FI870457A0/fi
Publication of FI870457L publication Critical patent/FI870457L/fi
Publication of FI86144B publication Critical patent/FI86144B/fi
Application granted granted Critical
Publication of FI86144C publication Critical patent/FI86144C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI870457A 1986-02-05 1987-02-03 Foerfarande foer framstaellning av farmaceutiska preparatformer foer topisk anvaendning foer stabilisering av -interferon. FI86144C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3603444 1986-02-05
DE19863603444 DE3603444A1 (de) 1986-02-05 1986-02-05 Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha

Publications (4)

Publication Number Publication Date
FI870457A0 FI870457A0 (fi) 1987-02-03
FI870457L true FI870457L (fi) 1987-08-06
FI86144B FI86144B (fi) 1992-04-15
FI86144C FI86144C (fi) 1992-07-27

Family

ID=6293372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870457A FI86144C (fi) 1986-02-05 1987-02-03 Foerfarande foer framstaellning av farmaceutiska preparatformer foer topisk anvaendning foer stabilisering av -interferon.

Country Status (20)

Country Link
EP (1) EP0231816B1 (fi)
JP (1) JPS62209024A (fi)
KR (1) KR870007698A (fi)
AT (1) ATE63823T1 (fi)
AU (1) AU601712B2 (fi)
CA (1) CA1295242C (fi)
DD (1) DD284602A5 (fi)
DE (2) DE3603444A1 (fi)
DK (1) DK164202C (fi)
ES (1) ES2028796T3 (fi)
FI (1) FI86144C (fi)
GR (1) GR3002270T3 (fi)
HU (1) HU196560B (fi)
IE (1) IE59697B1 (fi)
IL (1) IL81472A0 (fi)
NO (1) NO169638C (fi)
NZ (1) NZ219169A (fi)
PH (1) PH24377A (fi)
PT (1) PT84243B (fi)
ZA (1) ZA87793B (fi)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5275804A (en) * 1986-02-25 1994-01-04 E. B. Michaels Research Associates, Inc. Process and composition for oral hygiene
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
DE3803312A1 (de) * 1988-02-04 1989-08-10 Gerd Prof Dr Med Gross Verwendung eines interferonenthaltenden gels
NO179479C (no) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat
DE68917883T2 (de) * 1988-05-06 1995-02-23 Toray Industries Stabile interferon-beta-zusammensetzung.
US5244652A (en) * 1991-03-22 1993-09-14 E. B. Michaels Research Associates, Inc. Viscous surface active composition
US5389676A (en) * 1991-03-22 1995-02-14 E. B. Michaels Research Associates, Inc. Viscous surfactant emulsion compositions
US5863530A (en) * 1991-10-11 1999-01-26 Spruson & Ferguson Treating ophthalmic fibrosis using interferon-α
WO1993006856A1 (en) * 1991-10-11 1993-04-15 Mark Cedric Gillies Treating ophthalmic fibrosis using interferon-alpha
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
FI106465B (fi) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
US6923966B2 (en) 1999-04-08 2005-08-02 Schering Corporation Melanoma therapy
JP4536194B2 (ja) * 2000-02-17 2010-09-01 大日本住友製薬株式会社 安定な注射用製剤
AU2001243431B2 (en) * 2000-03-07 2006-05-25 Rush University Medical Center Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa
US6328987B1 (en) * 2000-11-03 2001-12-11 Jan Marini Skin Research, Inc. Cosmetic skin care compositions containing alpha interferon
KR20050042032A (ko) * 2001-11-02 2005-05-04 세키스이가가쿠 고교가부시키가이샤 사이토카인 유도 재료 및 사이토카인 유도 용구
US8137677B2 (en) * 2005-10-06 2012-03-20 Allergan, Inc. Non-protein stabilized clostridial toxin pharmaceutical compositions
SG176254A1 (en) * 2009-05-29 2011-12-29 Filligent Ltd Composition for use in decreasing the transmission of human pathogens
DK2819682T3 (en) * 2012-03-01 2017-08-21 Firststring Res Inc TOPICAL GELLS CONTAINING ALPHA-CONNEXIN C-TERMINAL (ACT) PEPTIDES
JP6081156B2 (ja) * 2012-11-15 2017-02-15 アルケア株式会社 ハイドロゲル
DE102012222365A1 (de) 2012-12-05 2014-06-05 Aesculap Ag Zusammensetzung zur Anwendung bei der Prophylaxe von post-chirurgischen Adhäsionen
CN105530950A (zh) * 2013-06-09 2016-04-27 艾弗兰纳特有限公司 包含Gc-巨噬细胞活化因子的组合物及其用途
BR112019013612B1 (pt) 2017-01-31 2022-08-09 Kimberly-Clark Worldwide, Inc Método para inibir o crescimento bacteriano em um produto, composição antibacteriana, e, lenço.
CN116710474A (zh) 2020-10-22 2023-09-05 撒凯尔生物公司 肽制剂及其眼科用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1234383A (en) * 1982-03-17 1983-09-22 Inter-Yeda Ltd. Interferon stabilised with polyvinyl-pyrrolidone
JPS6061535A (ja) * 1983-08-24 1985-04-09 エフ・ホフマン・ラ・ロシユ・ウント・コンパニ−・アクチエンゲゼルシヤフト 製薬学的組成物
JPS6069037A (ja) * 1983-09-26 1985-04-19 Sunstar Inc エリテマト−デス治療用外用剤
EP0139286B1 (en) * 1983-10-14 1991-08-21 Sumitomo Pharmaceuticals Company, Limited Prolonged sustained-release preparations
US4680175A (en) * 1984-02-07 1987-07-14 Interferon Sciences, Inc. Interferon administration vehicles
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
JPS60260523A (ja) * 1984-06-07 1985-12-23 Asahi Chem Ind Co Ltd インタ−フエロンの凍結乾燥医薬組成物

Also Published As

Publication number Publication date
DK58387A (da) 1987-08-06
NO169638B (no) 1992-04-13
NO870441L (no) 1987-08-06
DK58387D0 (da) 1987-02-04
DK164202C (da) 1992-10-19
PH24377A (en) 1990-06-13
ES2028796T3 (es) 1992-07-16
FI86144B (fi) 1992-04-15
ATE63823T1 (de) 1991-06-15
JPS62209024A (ja) 1987-09-14
DD284602A5 (de) 1990-11-21
HUT43494A (en) 1987-11-30
NO870441D0 (no) 1987-02-04
IL81472A0 (en) 1987-09-16
CA1295242C (en) 1992-02-04
DE3770280D1 (de) 1991-07-04
EP0231816A3 (en) 1987-09-23
KR870007698A (ko) 1987-09-21
ZA87793B (en) 1988-10-26
DE3603444A1 (de) 1987-08-06
HU196560B (en) 1988-12-28
NO169638C (no) 1992-07-22
PT84243B (pt) 1989-09-14
GR3002270T3 (en) 1992-12-30
FI870457A0 (fi) 1987-02-03
DK164202B (da) 1992-05-25
IE870295L (en) 1987-08-05
EP0231816A2 (de) 1987-08-12
PT84243A (de) 1987-03-01
AU601712B2 (en) 1990-09-20
IE59697B1 (en) 1994-03-23
NZ219169A (en) 1990-04-26
AU6829287A (en) 1987-08-06
EP0231816B1 (de) 1991-05-29
FI86144C (fi) 1992-07-27

Similar Documents

Publication Publication Date Title
FI863362L (fi) Farmaceutisk sammansaettning.
DE3783437D1 (de) Heilmittel.
FI870457L (fi) Farmaceutiska preparatformer foer stabilisering av interferon.
FI871750L (fi) Nasal administration av laekemedel.
FI875326L (fi) Ljusbestraolningsanordning foer medicinal vaord av oera.
FI873113L (fi) Tvaettmedelskomposition.
FI885026L (fi) Haorvaordsmedel.
FI875046L (fi) Foerfarande foer framstaellning av ren dimetyleter.
FI872733A0 (fi) Farmaceutiska kompositioner.
FI871682A0 (fi) Anordning foer foerspaenning av glasskivor.
FI872313A0 (fi) Farmaceutiska kompositioner.
FI875245L (fi) Foerfarande foer oekande av utsoendringen av adenosin.
NO874193D0 (no) Farmasoeytiske preparater.
DE3763519D1 (de) Heilnahrungsmittel.
FI874414A0 (fi) Kontrollerat frigoerande farmaceutiska kompositioner.
FI852658A0 (fi) Farmaceutiska aemnen.
FI875616A0 (fi) Farmaceutiska blandningar.
NO882264L (no) Legemiddelpakning.
FI875325A0 (fi) Bestraolningsanordning foer synbart ljus vid medicinal anvaendning.
NO875121D0 (no) Medikamenteringsform.
FI865010A0 (fi) Farmaceutisk aemnesklass.
NO874852D0 (no) Farmasoeytiske blandinger.
IT8619483A0 (it) Composizioni farmaceutiche.
MX9203545A (es) Formulaciones farmaceuticas.
IT8719708A0 (it) Formulazione farmaceutica.

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: DR. KARL THOMAE GESELLSCHAFT MIT